B6.129S-Tnfrsf1atm1Gkl/Flmg
Status | Available to order |
EMMA ID | EM:11071 |
International strain name | B6.129S-Tnfrsf1atm1Gkl/Flmg |
Alternative name | B6.Cg-Tnfrsf1a |
Strain type | Targeted Mutant Strains : Conditional mutation |
Allele/Transgene symbol | Tnfrsf1atm1Gkl, |
Gene/Transgene symbol | Tnfrsf1a |
Information from provider
Provider | George Kollias |
Provider affiliation | BSRC Fleming |
Genetic information | A mutation deleting 15 nucleotides encoding amino acids 202-206 was introduced in exon 6 of mp55TNFR (Tnfrsf1a) gene. The targeting vector contained a 4.6-kb XbaI/SmaI genomic fragment as the left homology arm and a 4-kb Sma/HindIII genomic fragment, containing the mutation, as the right homology arm. A loxP flanked neo selection cassette (L2neo) was introduced into a SmaI site in intron 5 of Tnfrsf1a gene between the two homology arms and a PGK-tk selection marker was introduced at the 3' of targeting vector. Upon cre-mediated recombination, a cell-specific Tnfrsf1a-tm1.1Gkl allele is generated. |
Phenotypic information | Homozygous:No overt phenotype. Homozygous mice are fertile but they are smaller than their littermates and in poor health so we do not mate the homozygous mice. Heterozygous:No overt phenotype |
Breeding history | Homozygous mice and wild-type controls are generated by crossing heterozygous mice. |
References |
|
Homozygous fertile | yes |
Homozygous viable | yes |
Homozygous matings required | no |
Immunocompromised | no |
Information from EMMA
Archiving centre | B.S.R.C. Alexander Fleming, Vari, Greece |
Animals used for archiving | homozygous C57BL/6, wild-type C57BL/6 |
Stage of embryos | 2-cell |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Tumor necrosis factor receptor 1 associated periodic syndrome / Orphanet_32960
MGI phenotypes (allele matching)
Literature references
- Tumor necrosis factor (TNF) receptor shedding controls thresholds of innate immune activation that balance opposing TNF functions in infectious and inflammatory diseases.;Xanthoulea Sofia, Pasparakis Manolis, Kousteni Stavroula, Brakebusch Cord, Wallach David, Bauer Jan, Lassmann Hans, Kollias George, ;2004;The Journal of experimental medicine;200;367-76; 15289505
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).